Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Cancer. 2015 May 29;121(17):3010–3017. doi: 10.1002/cncr.29472

Table 2.

Association between BF and BMI and covariates

Variable HR* 95% CI p-value
BMI, continuous(kg/m2) 1.03 1.00–1.07 0.042
Log iPSA(ng/mL) 2.02 1.60–2.52 <0.001
Age(years) 1.00 0.98–1.02 0.992
ADT Use(yes vs no) 0.74 0.47–1.17 0.192
Comorbidities(yes vs no)
Diabetes 1.09 0.71–1.69 0.691
Hypertension 1.17 0.83–1.66 0.373
Heart Disease 0.80 0.51–1.25 0.322

BF, biochemical failure; BMI, body mass index; HR, hazard ratio; ADT, androgen deprivation therapy; iPSA, pre-treatment prostate specific antigen.

*

Hazard ratios are from a single stratified Cox proportional hazards model, adjusted for T-stage and Gleason score as stratification variables.